CLONEPIX2
Ended Purchase Order Awarded Last action
- Contract number
- 75F40120P00210
- Awardee
-
Molecular Devices LLC UEI L64RUJ7LC8T9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $985,011
Award facts
- Opportunity
-
- FDA20RFQ1223316 Solicitation number
- Contract value 96% obligated
-
- $985,011.00 Current, with exercised options
- $1,021,272.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $36,261 | |
| Exercise an Option | $36,261 | |
| Original award | $912,489 |
About this award
The Food and Drug Administration awarded a $1.02M firm fixed-price purchase order to Molecular Devices LLC on July 23, 2020, for robotic arm replacement on CLONEPIX2 equipment. The contract, which carries no set-aside designation, was performed in Silver Spring, Maryland, with an ultimate completion date of September 2, 2024. Molecular Devices LLC, a San Jose-based subsidiary of Danaher Corporation, is a leading manufacturer of advanced bioanalytical measurement solutions and specialized laboratory instruments serving federal agencies across the life sciences and pharmaceutical research sectors.
The scope of work involves replacement components for the CLONEPIX2 system, a high-content imaging platform used in pharmaceutical development and biotherapeutic research. Molecular Devices maintains a robust federal contracting presence, particularly with the National Institutes of Health, CDC, and FDA, providing equipment, maintenance agreements, and repair services. As the original equipment manufacturer with proprietary technologies, the company typically receives non-competitive awards reflecting its specialized market position and critical role in supporting federal research infrastructure.
Quick answers
Who was awarded contract 75F40120P00210?
75F40120P00210 was awarded to Molecular Devices LLC by Food and Drug Administration (Department of Health and Human Services) on July 23, 2020.
How much is contract 75F40120P00210 worth?
The government has obligated $985,011 on 75F40120P00210. Its potential value, with all options, is $1,021,272.
Was contract 75F40120P00210 competed?
The extent of competition for 75F40120P00210 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award